Skip to content
Chemcrux Enterprises logo

Chemcrux Enterprises

CHEMCRUX NSE
₹81.40 down 0.08 (0.10%)
Market Cap
₹121 Cr
P/E
29.07

Chemcrux Enterprises (CHEMCRUX) share price was ₹81.48 at the 28 Oct 2026 close; market capitalisation ₹121 Cr; P/E (TTM) 29.10; sector Chemicals. The share price fell 25.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 33.0% year on year to ₹21.94 Cr and net profit was ₹0.51 Cr, against ₹0.09 Cr a year earlier (compared with Jun 2025). Promoters held 72.92% of Chemcrux Enterprises in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹81.48 −29.12 −26.33% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹121 Cr
P/E (TTM)
29.07
EBITDA
₹13.20 Cr
Return on Equity
4.85%
Debt to Equity
0.45
Book Value
₹51.90
EPS (TTM)
₹2.80
52W High
₹158.60
52W Low
₹64.00

Price-based figures as of 29 Oct 2026, 10:37 IST · EPS basis: Consolidated · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,378.4052.971,40,305 Cr12.961.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,241.4077.0046,592 Cr5.960.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,383.5054.4243,001 Cr10.820.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,583.5089.3121,017 Cr8.560.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,484.6025.8520,249 Cr3.470.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹451.9030.8716,386 Cr2.750.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,166.0019.7015,210 Cr2.310.55%10.95%13.54%7,185 Cr788 Cr
Chemcrux Enterprises (this company)
₹81.4029.07121 Cr1.571.27%4.85%8.17%88 Cr4 Cr
Median 8 companies₹1,534.0541.9220,633 Cr4.720.38%9.16%11.50%6,260 Cr692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 98/100

Category scores

Quality Strong 81
Returns, margins, earnings quality 22% weight
Valuation Average 47
Cheap vs sector & own history 24% weight
Growth Strong 67
Sales & profit trajectory 9% weight
Financial Health Weak 40
Solvency, leverage, coverage 9% weight
Momentum Weak 43
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 31.7%
  • Company's working capital requirements have reduced from 33.2 days to 16.2 days

Weaknesses

1
  • Company has a low return on equity of 6.46% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
8
Neutral
7
Bullish
4

Moving Averages

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
15.66% higher than 3Y

change over 1 year

Net Income Growth
-5.13% higher than 3Y

change over 1 year

Cash Flow Change
82.48%

change over 1 year

EBITDA Margin Change
6.2%

change over 1 year Operating margin 12.31% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
22.29
15.84
21.81
18.54
17.11
17.76
19.42
15.72
16.5
17.75
22.11
24.28
21.94
Expenses
18.43
13.5
17.43
15.92
15.05
15.4
16.73
13.61
14.87
15.96
18.58
20.1
19.24
Operating Profit
3.86
2.34
4.38
2.62
2.06
2.36
2.69
2.11
1.63
1.79
3.53
4.18
2.7
OPM %
17.32%
14.77%
20.08%
14.13%
12.04%
13.29%
13.85%
13.42%
9.88%
10.08%
15.97%
17.22%
12.31%
Other Income
0.18
0.24
0.56
0.35
0.39
0.26
0.61
0.24
0.44
0.63
0.6
0.36
0.11
Interest
0.31
0.21
0.17
0.13
0.13
0.33
0.6
0.69
0.86
0.83
0.76
0.7
0.64
Depreciation
0.57
0.58
0.58
0.55
0.56
0.73
0.92
0.99
1.18
1.2
1.19
1.17
1.18
PBT
3.16
1.79
4.19
2.29
1.76
1.56
1.78
0.67
0.03
0.39
2.18
2.67
0.99
Tax %
26.27%
30.17%
36.75%
3.49%
29.55%
26.28%
25.84%
68.66%
-233.33%
46.15%
27.98%
30.71%
48.48%
Net Profit
2.33
1.24
2.66
2.21
1.24
1.15
1.32
0.21
0.09
0.21
1.58
1.85
0.51
EPS (₹)
1.57
0.84
1.8
1.49
0.84
0.78
0.89
0.14
0.06
0.14
1.07
1.25
0.34
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
95.27
95.15
78.47
70.01
80.65
86.08
Expenses
74.56
73.69
65.1
60.78
69.5
73.88
Operating Profit
20.71
21.46
13.37
9.23
11.15
12.2
OPM %
21.74%
22.55%
17.04%
13.18%
13.83%
14.17%
Other Income
1
1.05
1.18
1.49
2.02
1.7
Interest
0.17
0.82
0.83
1.75
3.15
2.93
Depreciation
1.59
2.04
2.29
3.21
4.73
4.74
PBT
19.95
19.65
11.43
5.76
5.29
6.23
Tax %
25.51%
26.92%
26.16%
32.12%
29.3%
—
Net Profit
14.86
14.36
8.44
3.91
3.73
4.15
EPS (₹)
10.03
9.7
5.7
2.64
2.52
2.8
Div. Payout %
19.93%
20.63%
17.55%
37.88%
39.71%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14.81
14.81
14.81
14.81
14.81
Reserves
39.87
51.6
57.45
59.81
62.04
Borrowings
9.75
14.43
26.46
42.3
34.37
Other Liabilities
19.34
12.38
11.15
10.13
16.22
Total Liabilities
83.77
93.22
110
127
127
Fixed Assets
25.49
33.11
33.09
77.06
74.96
CWIP
0
0.31
21.06
1.61
4.08
Investments
7.08
16.79
19.83
19.83
15.93
Other Assets
51.2
43.01
35.89
28.55
32.47
Total Assets
83.77
93.22
110
127
127
Figures in ₹ Crores

Cash Flow

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9.16
14.82
16.34
7.59
13.85
Investing
-2.64
-20.48
-25.89
-5.98
-0.07
Financing
3.96
0.96
7.64
-5.66
-12.36
Net Cash Flow
10.49
-4.7
-1.91
-4.04
1.42
Free Cash Flow
4.59
3.71
-6.85
-0.64
8.74
CFO/OP
69
86
142
98
136
Figures in ₹ Crores

Ratios

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
72.33
51.56
71.17
61.42
85.58
Inventory Days
92.33
125
99.63
135
69.24
Days Payable
92.57
71.19
70.84
60.56
105
Cash Conversion Cycle
72.09
105
99.96
136
49.43
Working Capital Days
37.43
67.28
55.49
27.94
16.16
ROCE %
—
27.63%
13.46%
6.69%
6.43%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chemcrux Enterprises insights

62 extracted metrics + investor summaries across FY16–FY27.

Shareholding Pattern

Promot.72.92%Others1.27%Public25.81%As ofSep 2026

Documents

Frequently Asked Questions about Chemcrux Enterprises

What does Chemcrux Enterprises Ltd do?
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]
Where is Chemcrux Enterprises Ltd (CHEMCRUX) listed?
Chemcrux Enterprises Ltd trades as CHEMCRUX on the NSE and under code 540395 on the BSE.
Which sector does Chemcrux Enterprises Ltd belong to?
Chemcrux Enterprises Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Chemcrux Enterprises Ltd?
Chemcrux Enterprises Ltd has a market capitalisation of ₹120.54 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Chemcrux Enterprises Ltd?
Chemcrux Enterprises Ltd trades at a PE ratio of 29.07 as of 29 Oct 2026, on earnings per share of ₹2.8, against a book value of ₹51.9 per share.
What is the 52-week high and low of Chemcrux Enterprises Ltd?
Over the last 52 weeks Chemcrux Enterprises Ltd has traded between ₹64 and ₹158.6 as of 29 Oct 2026.
Does Chemcrux Enterprises Ltd pay dividends?
Chemcrux Enterprises Ltd has a dividend yield of 1.23%.
What is the Return on Equity (ROE) of Chemcrux Enterprises Ltd?
Chemcrux Enterprises Ltd reported a return on equity of 4.85%. Its debt-to-equity ratio is 0.45.

Company Information

Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]

Website chemcrux.com
Listed 2017-03-28
Face Value ₹ 10
Shares Outstanding 1,48,08,840

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540395.md for Chemcrux Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month